[Research progress of cell therapy in hereditary pulmonary alveolar proteinosis].
Zhonghua Jie He He Hu Xi Za Zhi
; 46(7): 730-734, 2023 Jul 12.
Article
en Zh
| MEDLINE
| ID: mdl-37402667
ABSTRACT
Hereditary pulmonary alveolar proteinosis (hPAP) is a rare interstitial lung disease caused by mutation in CSF2RA/CSF2RB, characterized by the deposition of pulmonary surfactant due to the alveolar macrophage dysfunction. The whole lung lavage can effectively alleviate the symptoms but is associated with potential complications. Cell therapy is a novel approach with advances that provide a new therapeutic strategy for the treatment of hPAP.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Proteinosis Alveolar Pulmonar
/
Surfactantes Pulmonares
Límite:
Humans
Idioma:
Zh
Revista:
Zhonghua Jie He He Hu Xi Za Zhi
Año:
2023
Tipo del documento:
Article